Stock Analiz

Innoviva, Inc. (INVA) stock forecast and price target

Price $19.03 · data as of November 13, 2026

12-month price target

Average target$34.80
Upside / downside+82.9%
Analysts5
ConsensusBuy
Low $18.00Average $34.80High $46.00

Gold marker: average target · white marker: today’s price ($19.03)

Analyst ratings

Strong buy 0Buy 4Hold 0Sell 1Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$0.86—$435M
Next fiscal year
ends December 31, 2027
$2.14—$475M
Next quarter
ends December 31, 2026
$0.45—$111M
Quarter after
ends March 31, 2027
$0.49—$113M

Consensus of the analysts covering Innoviva, updated daily.

Our model vs. Wall Street

Analysts see 82.9% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Innoviva’s intrinsic value about 177% above today’s market value, and it scores 3.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Innoviva stock price target?

The average 12-month target from 5 analysts is $34.80, 82.9% above the current price of $19.03 Targets range from $18.00 to $46.00.

Is Innoviva a buy according to analysts?

The consensus rating is “Buy” (4 buy, 1 sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Innoviva expected to earn?

Analysts expect EPS of $0.86 for the fiscal year ending December 31, 2026 and $2.14 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.